Episode

LTR 151: Sarai Pahla on Managing Supply Chain Disruption Risk in Life Sciences

Podcast
Let's Talk Risk! Podcast
Published
Apr 17, 2026
Duration seconds
1561
Processing state
not_requested
Canonical source
https://naveenagarwalphd.substack.com/p/ltr-151-sarai-pahla-on-managing-supply-chain-disruption-risk
Audio
https://api.substack.com/feed/podcast/193690810/c4af0793d8527e8712591f52b31b5d10.mp3
JSON
/v1/public/podcasts/let-s-talk-risk-podcast-6693844/episodes/ltr-151-sarai-pahla-on-managing-supply-chain-disruption-risk-in-life-sciences
Markdown
/podcast/let-s-talk-risk-podcast-6693844/ltr-151-sarai-pahla-on-managing-supply-chain-disruption-risk-in-life-sciences.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/let-s-talk-risk-podcast-6693844/episodes/ltr-151-sarai-pahla-on-managing-supply-chain-disruption-risk-in-life-sciences/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/let-s-talk-risk-podcast-6693844/ltr-151-sarai-pahla-on-managing-supply-chain-disruption-risk-in-life-sciences.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Summary “Loss of service or device is loss of benefit, which means it naturally increases the risk of our device.” What happens when a highly regulated medical device depends on a tiny, single-sourced component buried deep in a fragile global supply chain? In this Let’s Talk Risk! conversation , host Naveen Agarwal speaks with Dr. Sarai Pahla about why supply chain disruption is no longer just an operations problem. It is a real risk issue for life sciences companies. Sarai brings a rare perspective to this conversation, combining medical training, ERP and IT experience, regulatory affairs, and multilingual medical writing. Together, we explore how supply shocks can disrupt patient access, why alternate sourcing is harder in regulated industries, and how predictive analytics may become essential for future supply chain resilience. Listen to the full 30-minute podcast or jump to a section of interest listed below. Chapters 00:00 Introduction 05:02 Why modern life sciences supply chains are more vulnerable to disruption 08:13 A real example of a single-source component risk in heart valve manufacturing 10:27 How supply chain disruption connects directly to patient benefit-risk 11:35 Planning ahead: second sources, business continuity, and R&D readiness 13:36 Why regulatory-ready suppliers create a strategic advantage 16:22 The role of AI and predictive analytics in supply chain risk management 23:34 Key takeaways: interdependence, relationships, and future-ready resilience If you enjoyed this podcast, consider subscribing to the Let’s Talk Risk! newsletter . Suggested links: LTR: Rethinking Supply Chain Risk: QMSR’s New Expectations LTR: It is Time to Focus on Supply Chain Resiliency Not Just Supplier Management . LTR: LTR Risk Coach - AI-Powered Decision Support Too…